KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients

Circulating free DNA (cfDNA) is obtained from serum or plasma by non-invasive methods such as a simple blood draw, a technique known as “liquid biopsy”. Genetic analyses of driver alterations in cfDNA have proved very effective to predict survival and treatment response of cancer patients according...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Transl Lung Cancer Res
Главные авторы: Garzón, Mónica, Villatoro, Sergi, Teixidó, Cristina, Mayo, Clara, Martínez, Alejandro, de los Llanos Gil, Maria, Viteri, Santiago, Morales-Espinosa, Daniela, Rosell, Rafael
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2016
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5099515/
https://ncbi.nlm.nih.gov/pubmed/27826532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.10.14
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы